You just read:

Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017

News provided by

Veracyte

May 10, 2017, 08:00 ET